The impact of exposure group on the progression rate to acquired immunodeficiency syndrome. A comparison between intravenous drug users, homosexual men and heterosexually infected subjects

Scandinavian Journal of Infectious Diseases

Volumn 29, Issue 2, 1997, Pages 103-109

  Eskild, Anne ^a   Magnus, Per ^a   Brekke, Trine ^a   Bruun, Johan N ^a   Heger, Bernt ^a   Frøland, Stig S ^a   Moi, Harald ^b   Samdal, Helvi Holm ^c   Løvik, Martinus ^b   Bakketeig, Leiv S ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HOMOSEXUALITY; HUMAN; INTRAVENOUS DRUG ABUSE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NORWAY; RISK; SEROCONVERSION;

EID: 0347203014     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549709035868     Document Type: Article

References (29)

1. Carre N, Deveau C, Belanger F, Boufassa F, Persoz A, Jadand C, Rouzioux C, Delfraissy JF, Bucquet D. Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients. AIDS 8: 797-802, 1994.
2. Mariotto AB, Mariotti S, Pezzotti P, Rezza G, Verdecchia A. Estimation of the acquired immunodeficiency syndrome incubation period in intravenous drug users: A comparison with male homosexuals. Am J Epidemiol 135: 428-437, 1992.
3. Biggar RJ and the International Registry of Seroconverters. AIDS incubation in 1891 HIV seroconverters from different exposure groups. AIDS 4: 1059-1066, 1990.
4. Galai N, Vlahov D, Margolick JB, Chen K, Graham NM, Munoz A. Changes in markers of disease progression in HIV-1 seroconverters: A comparison between cohorts of injecting drug users and homosexual men. J Acquir Immun Defic Syndr 8: 66-74, 1995.
5. Spijkerman IJ, Koot M, Prins M, Keet IP, van-den-Hoek-AJ, Miedema F, Coutinho RA. Lower prevalence and incidence of HIV-1 syncytium-inducing phenotype among injecting drug users compared with homosexual men. AIDS 9: 1085-1092. 1995.
6. Centers for Disease Control. Revision of the CDC surveillance case definition of the acquired immunodeficiency syndrome. MMWR 36 Suppl 1: 3-15, 1987.
7. Centers for Disease Control. Classification system for human T-lymphotropic virus type III/lymphadenopathy associated virus infections. MMWR 35: 334-339, 1986.
8. Dobloug JH, Bruun JN, Skaug K. The early introduction of HIV infection among Norwegians at highest risk. Scand J Infect Dis 22: 753-754, 1990.
9. Directorate of Health, Norway. Notification of HTLV III/ ILAV infections (in Norwegian). Directorate of Health. Oslo, 1986.
10. Nilsen Ø, Hasseltvedt V, Lystad A. Number of HIV and AIDS cases in Norway (in Norwegian). Notification system for infectious diseases in Norway (MSIS-rapport), National Institute of Public Health. Oslo 23 (23), 1995.
11. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 53: 457-481, 1958.
12. Cox DR, Oaks D. Analysis of Survival Data. New York: Chapman and Hall, 1984.
13. SPSS Base System Reference Guide, Release 6.1. SPSS Inc, 1994.
14. Margolick JB, Munoz A, Vlahov D, Solomon L, Astemborski J, Cohn S, Nelson KE. Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection. JAMA 267: 1631-1636, 1992.
15. Mientjes GHC, van Ameijden EJC van den Hoek AJAR, Goudsmit J, Miedema F, Coutinho RA. Progression of HIV infection among injecting drug users: indications for a lower rate of progression among those who have frequently borrowed injecting equipment. AIDS 7: 1363-1370, 1993.
16. Eskild A, Magnus P, Sohlberg C, Kittelsen P, Olving J, Teige K, Skullerud K. Slow progression to AIDS among intravenous drug users infected with HIV in Norway. J Epidemiol Commun Health 48: 383-387, 1994.
17. Vella S, Giuliano M, Flordia M, Chiesi A, Tomino C, Seeber A, Barcherini S, Bucciardini R, Mariotti S. Effect of sex, age and transmission category on the progression to AIDS and survival of zidovudine-treated symptomatic patients. AIDS 9: 51-56, 1995.
18. Coates RA, Farewell VT, Raboud J, Read SE, MacFadden DK, Calzavara LM, Johnson JK, Shepherd FA, Fanning MM. Cofactors of progression to acquired immunodeficiency syndrome in a cohort of male sexual contacts of men with human immunodeficiency virus disease. Am J Epidemiol 132: 717-722, 1990.
19. Brookmeyer R, Gail MH, Polk B. The prevalent cohort study and the acquired immunodeficiency syndrome. Am J Epideniol 126: 14-24, 1987.
20. Magnus P, Samuelsen SO, Eskild A, Stigum H. HIV testing in the Norwegian population and the association with sexual behaviour (in Norwegian). J Nor Med Assoc 114: 3064-3067, 1994.
21. Alcabes P, Munoz A, Vlahov D, Friedland GH. Incubation period of Human Immunodeficiency Virus. Epidemiol Rev 15: 303-318, 1993.
22. Eskild A, Magnus P, Samuelsen SO. Sohlberg C, Kittelsen K. Differences in mortality rates and causes of death between HIV-positive and HIV-negative intravenous drug users. Int J Epidemiol 22: 315-20, 1993.
23. Webster A Lee CA, Cook-DG, Grundy-JE, Emery VC, Kernoff PB, Griffiths PD. Cytomegalovirus infection and progression towards AIDS in haemophiliacs infected with human immunodeficiency virus. Lancet 2: 63-66, 1989.
24. Eskild A, Magnus P, Petersen G, Sohlberg C, Jensen F, Kittelsen P, Skaug K. Hepatitis B antibodies in HIV-infected homosexual men are associated with more rapid progression to AIDS. AIDS 6: 571-574, 1992.
25. Phair J, Jacobson L, Detels R, Rinaldo C, Saah A, Schrager L, Munoz A. Aquired immunodeficiency syndrome occuring within 5 years of infection with human immunodeficiency virus type 1: The multicenter AIDS cohort study. J Aquir Immun Defic Syndr 5: 490-496, 1992.
26. Flateby G, Eskild A, Brekke T, Moi H. Steady sexual relationship with a HIV-positive partner and the progression rate to AIDS. AIDS 10: 1749-1751, 1996.
27. Rojas JM, Dopazo J, Najera I, Sanchez-Palomino S, Olivares I; Martin MJ, Bernai A, Garcia-Saiz A; Najera R, Lopez-Galindez C. Molecular epidemiology of HIV in Madrid. Virus Res 31: 331-342, 1994.
28. Kuicken CL, Zwart G, Baan E, Coutinho RA, van den Hoek AR, Goudsmit J. Increasing antigenic diversity of the V3 variable domain of the Human immunodeficiency virus envelope protein in the course of the AIDS epidemic. Proc Natn Acad Sci USA 90: 9061-9065, 1993.
29. Engelstad M. Genetic diversity of env V3 loop sequences in HIV type-1 infected homosexuals, heterosexuals, intravenous drug users and hemophilia patients in Norway: high prevalence of subtype B and detection of subtype C. AIDS Res Hum Retrovir 12: 1733-1738, 1996.